AU3036197A - Adenovirus vectors for gene therapy - Google Patents

Adenovirus vectors for gene therapy

Info

Publication number
AU3036197A
AU3036197A AU30361/97A AU3036197A AU3036197A AU 3036197 A AU3036197 A AU 3036197A AU 30361/97 A AU30361/97 A AU 30361/97A AU 3036197 A AU3036197 A AU 3036197A AU 3036197 A AU3036197 A AU 3036197A
Authority
AU
Australia
Prior art keywords
gene therapy
adenovirus vectors
adenovirus
vectors
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30361/97A
Inventor
Pierre Leroy
Monika Lusky
Majid Mehtali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Publication of AU3036197A publication Critical patent/AU3036197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
AU30361/97A 1996-05-20 1997-05-20 Adenovirus vectors for gene therapy Abandoned AU3036197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9606213A FR2748753B1 (en) 1996-05-20 1996-05-20 NEW ADENOVIRAL VECTORS FOR GENE THERAPY
FR9606213 1996-05-20
PCT/FR1997/000882 WO1997044475A1 (en) 1996-05-20 1997-05-20 Adenovirus vectors for gene therapy

Publications (1)

Publication Number Publication Date
AU3036197A true AU3036197A (en) 1997-12-09

Family

ID=9492265

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30361/97A Abandoned AU3036197A (en) 1996-05-20 1997-05-20 Adenovirus vectors for gene therapy

Country Status (3)

Country Link
AU (1) AU3036197A (en)
FR (1) FR2748753B1 (en)
WO (1) WO1997044475A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782732A1 (en) * 1998-08-28 2000-03-03 Transgene Sa INDUCTIBLE EXPRESSION SYSTEM
DE19856065A1 (en) * 1998-12-04 2000-06-15 Centeon Pharma Gmbh Recombinant, adenoviral vector with limited auto-replication ability in vivo
EP1227837B1 (en) 1999-10-22 2008-05-21 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
ES2276788T3 (en) 2000-05-10 2007-07-01 Sanofi Pasteur Limited IMMUNOGEN POLIPEPTIDES CODED BY MAGE MINIGENS AND THEIR USES.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003769A1 (en) * 1991-08-20 1993-03-04 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTEMENT OF HEALTH AND HUMAN SERVICES Adenovirus mediated transfer of genes to the gastrointestinal tract
US5820868A (en) * 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
FR2726285B1 (en) * 1994-10-28 1996-11-29 Centre Nat Rech Scient ADENOVIRUSES CONTAINING VIABLE CONTAMINANT PARTICLES, PREPARATION AND USE

Also Published As

Publication number Publication date
FR2748753A1 (en) 1997-11-21
FR2748753B1 (en) 1998-08-14
WO1997044475A1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
EP0710123A4 (en) Adenovirus vectors for gene therapy sponsorship
AU4787697A (en) Therapeutic gene
AU2552795A (en) Safe vectors for gene therapy
AU699706C (en) Improved vectors for gene therapy
AU4255397A (en) Chimpanzee adenovirus vectors
AU2319497A (en) Helper-free, totally defective adenovirus for gene therapy
AU5153296A (en) Vectors for gene delivery
AU3739697A (en) Gene delivery system
EP1109896A4 (en) Adenovirus formulations for gene therapy
AU5723696A (en) Gene therapy using replication competent targeted adenoviral vectors
AUPO203996A0 (en) Therapeutic uses
AU3737297A (en) Bacteriophage-mediated gene therapy
AU6139498A (en) Multi-speaker storytelling system
AU2891397A (en) Triazolyl disulphides
AU3169495A (en) Gene therapy for restenosis using an adenoviral vector
AU5246398A (en) Magnetic therapy
AU4401297A (en) Improved retroviral vectors for gene therapy
AUPO434196A0 (en) An improved therapeutic
AU3036197A (en) Adenovirus vectors for gene therapy
AU4941096A (en) Self-deleting vectors for gene therapy
AUPO060996A0 (en) Sexing gene
AU7936898A (en) Vectors for treating cancer
EP1084236A4 (en) Novel adenoviral vectors for gene therapy
AU4582597A (en) Therapeutic proteins
AU2002227270A1 (en) Afterloader apparatus